Health and Fitness Health and Fitness
Thu, October 13, 2011
[ Thu, Oct 13th 2011 ] - Market Wire
Strong Pipelines From Allos Therapeutics and Dynavax Tech Poised to Pay Off
[ Thu, Oct 13th 2011 ] - Market Wire
Mercka?s ISENTRESS® (raltegravir) in Combination .. cal and Immunological Efficacy Versus the Efavire
[ Thu, Oct 13th 2011 ] - Market Wire
Synageva BioPharma and Trimeris Announce Special Meetings of Stockholders to Approve Merger
[ Thu, Oct 13th 2011 ] - Market Wire
AMRI Appoints New President, India Operations and .. of Project Management a" Pharmaceutical Services
[ Thu, Oct 13th 2011 ] - Market Wire
Vanguard Health Systems Appoints Former Tennessee Governor to Board of Directors
[ Thu, Oct 13th 2011 ] - Market Wire
Horizon Pharma Receives U.S. Patent Allowance for DUEXIS(R) in the United States
[ Thu, Oct 13th 2011 ] - Market Wire
Micromet Obtains FDA Feedback on Registration Strategy for Blinatumomab in Relapsed/Refractory ALL
[ Thu, Oct 13th 2011 ] - Market Wire
POZEN Reports Top-Line Data from Long-Term Safety Study of PA32540
[ Thu, Oct 13th 2011 ] - Market Wire
Galectin Therapeutics to Announce New Data on the Treatment of Fatty Liver Disease and Fibrosis
[ Thu, Oct 13th 2011 ] - Market Wire
U.S. Sales of EGRIFTA(R) Driving Revenue Growth
[ Thu, Oct 13th 2011 ] - Market Wire
Los datos presentados durante el 5 Congreso trien .. or ECTRIMS y ACTRIMS demuestran el compromiso y l
[ Thu, Oct 13th 2011 ] - Market Wire
ISTA Pharmaceuticals Announces Statistically Significant Phase 3 Results for PROLENSA(TM)
[ Thu, Oct 13th 2011 ] - Market Wire
ISTA Pharmaceuticals Reports Results From the Sec .. URA(TM) Phase 3 Clinical Program for Dry Eye Dise
[ Thu, Oct 13th 2011 ] - Market Wire
China Medical Technologies Receives SFDA Approval .. ed KRAS Assay for Colorectal Cancer Targeted Drug
Wed, October 12, 2011
[ Wed, Oct 12th 2011 ] - Market Wire
Financial Statement 10/11
[ Wed, Oct 12th 2011 ] - Market Wire
Neue Daten, die auf dem 5. gemeinsamen Kongress v .. tellt werden, zeigen neue Forschungsanstze von Bi
[ Wed, Oct 12th 2011 ] - Market Wire
Cumberland Pharmaceuticals Appoints Rick S. Greene Chief Financial Officer
[ Wed, Oct 12th 2011 ] - Market Wire
Savient Pharmaceuticals to Hold Third Quarter 201 .. lts Conference Call on Thursday, November 3, 2011
[ Wed, Oct 12th 2011 ] - Market Wire
Helix BioPharma Corp. Files IND Clinical Hold Res .. d Topical Interferon Alpha-2b Phase II/III Effica
[ Wed, Oct 12th 2011 ] - Market Wire
Mylan Announces Intention to Refinance Existing Secured Credit Facility
[ Wed, Oct 12th 2011 ] - Market Wire
Ion Torrent Gets Better Faster With 4th Qtr New Product Releases
[ Wed, Oct 12th 2011 ] - Market Wire
Tornier Announces Conference Call of Third Quarter Results
[ Wed, Oct 12th 2011 ] - Market Wire
The Medicines Company to Announce Third Quarter 2 .. Financial Results on Wednesday, October 26, 2011
[ Wed, Oct 12th 2011 ] - Market Wire
Assisted Living Concepts, Inc. Schedules Third Quarter Financial Results Conference Call
[ Wed, Oct 12th 2011 ] - Market Wire
Dynavax to Host Analyst &;; Investor Day Webcast October 27, 2011
[ Wed, Oct 12th 2011 ] - Market Wire
Gegevens gepresenteerd op het vijfde gezamenlijke .. CTRIMS en ACTRIMS tonen de innovatieve wetenschap
[ Wed, Oct 12th 2011 ] - Market Wire
Micro Imaging Technology Announces a Date for Its Annual General Shareholders Meeting
[ Wed, Oct 12th 2011 ] - Market Wire
Cubist Pharmaceuticals to Announce Third Quarter .. Financial Results on Wednesday, October 19, 2011
[ Wed, Oct 12th 2011 ] - Market Wire
ProMetic Announces Resumption of Prion Capture Resin Supply to Octapharma
[ Wed, Oct 12th 2011 ] - Market Wire
Media Advisory/REMINDER: Theratechnologies to Announce Financial Results for Third Quarter of 2011

Media Advisory/REMINDER: Theratechnologies to Announce Financial Results for Third Quarter of 2011


Published on 2011-10-12 07:07:28 - Market Wire
  Print publication without navigation


October 12, 2011 10:00 ET

Media Advisory/REMINDER: Theratechnologies to Announce Financial Results for Third Quarter of 2011

MONTREAL, QUEBEC--(Marketwire - Oct. 12, 2011) - Theratechnologies Inc. (TSX:TH)(NASDAQ:THER) (Theratechnologies) announced today that it will issue its financial results for the third quarter of 2011 on Thursday, October 13, 2011, before markets open.

A conference call will be held the same day at 8:30 a.m. ET to discuss the third quarter results. The call will be hosted by John-Michel T. Huss, President and Chief Executive Officer, and Luc Tanguay, Senior Executive Vice President and Chief Financial Officer. The conference call is open to questions from financial analysts. Media and other interested individuals are invited to participate in the call on a "listen-only" basis.

The conference call can be accessed by dialling 1-800-954-0647 (North America) or 1-416-981-9000 (International). The conference call will also be accessible via webcast at [ www.theratech.com ]. Audio replay of the conference call will be available until October 27, 2011 by dialling 1-800-558-5253 (North America) or 1-416-626-4100 (International) and by entering the playback code 21539749.



Contributing Sources